Variations in Retinal Nerve Fiber Layer Thickness During Uncomplicated Anterior and Intermediate Uveitis
NCT02879084 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36
Last updated 2021-01-27
Summary
This study investigates the variations in the retinal nerve fiber layer (RNFL) thickness during uncomplicated anterior and intermediate uveitis, respectively. The objectives are to 1 ) confirm the RNFL thickening during an uncomplicated anterior uveitis as described in the literature, 2) measure the RNFL thickness during an uncomplicated intermediate uveitis specifically and 3) describe the variation in time of RNFL thickness during the two types of uveitis.
Conditions
- Anterior Uveitis
- Intermediate Uveitis
Sponsors & Collaborators
-
CHU de Quebec-Universite Laval
lead OTHER
Principal Investigators
-
Simon Couture, Doctor · Centre de recherche du CHU de Québec : Université Laval
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-08-31
- Primary Completion
- 2020-12-31
- Completion
- 2020-12-31
Countries
- Canada
Study Locations
More Related Trials
-
Prognostic Factors for Visual Improvement in Patients Undergoing Intravitreal Ranibizumab for Retinal Vein Occlusion
NCT02144662 ·Status: COMPLETED ·Phase: NA
-
Evaluation and Treatment of Patients With Inflammatory Eye Diseases
NCT00006188 ·Status: COMPLETED
-
A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants
NCT07218770 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion
NCT02169648 ·Status: UNKNOWN ·Phase: NA
-
Daclizumab and Sirolimus to Treat Uveitis
NCT00078689 ·Status: COMPLETED ·Phase: PHASE1
-
Immune Indicators of Uveitis
NCT00089739 ·Status: COMPLETED
-
Prevention of Vision Loss in Patients With Age-Related Macular Degeneration (AMD) by Intravitreal Injection of Bevacizumab and Ranibizumab
NCT00559715 ·Status: UNKNOWN ·Phase: PHASE3
-
Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Uveitic Macular Edema
NCT00958906 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab
NCT03056092 ·Status: UNKNOWN ·Phase: PHASE4
-
Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis
NCT00070759 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarkers in Ocular Inflammation and Uveitis
NCT04690829 ·Status: COMPLETED
-
Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab
NCT00605943 ·Status: COMPLETED
-
Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy
NCT01256632 ·Status: COMPLETED ·Phase: NA
-
To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema
NCT01846299 ·Status: COMPLETED ·Phase: PHASE3
-
REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study
NCT01247220 ·Status: COMPLETED ·Phase: PHASE2
-
Analysis of naïve Patients With Age-related Macular Degeneration Neovascular Type and Treated With Ranibizumab (Lucentis®) in Treat-and-extend at the CHU Brugmann.
NCT04988178 ·Status: COMPLETED
-
Subfoveal Choroidal Thickness and Visual Acuity After Intravitreal Injection of Ranibizumab in Diabetic Retinopathy
NCT06173245 ·Status: COMPLETED ·Phase: NA
-
Intraocular Cytokines in Non-responders to Ranibizumab Treatment for Neovascular AMD
NCT02218177 ·Status: COMPLETED
-
The Cohort Study of Uveitis Patients
NCT05727540 ·Status: RECRUITING
-
Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments
NCT00749021 ·Status: COMPLETED ·Phase: PHASE1
-
Injected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel Formation
NCT00457145 ·Status: COMPLETED ·Phase: PHASE1
-
Ranibizumab Treatment for Retinal Vein Occlusion
NCT01968616 ·Status: UNKNOWN ·Phase: NA
-
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
NCT01135914 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate
NCT01314417 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Intravitreal Celecoxib for Chronic Uveitis
NCT02131012 ·Status: TERMINATED ·Phase: PHASE1